Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules

Conditions:   Healthy Volunteers;   Bioequivalence Study Interventions:   Drug: Neurogabin (Gabapentin) 400 mg capsule;   Drug: Parketin (Gabapentin) 400 mg capsule Sponsors:   University of Karachi;   Merck Pvt. Ltd, Pakistan;   Center for Bioequivalence Studies and Clinical Research (CBSCR), HEJ Research Institute of chemistry, University of Karachi Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials